LivaNova (LIVN) Competitors

$61.95
-0.46 (-0.74%)
(As of 05/9/2024 ET)

LIVN vs. ITGR, TMDX, CNMD, HAE, SLNO, INMD, BLFS, AXGN, OM, and MASI

Should you be buying LivaNova stock or one of its competitors? The main competitors of LivaNova include Integer (ITGR), TransMedics Group (TMDX), CONMED (CNMD), Haemonetics (HAE), Soleno Therapeutics (SLNO), InMode (INMD), BioLife Solutions (BLFS), AxoGen (AXGN), Outset Medical (OM), and Masimo (MASI). These companies are all part of the "medical" sector.

LivaNova vs.

LivaNova (NASDAQ:LIVN) and Integer (NYSE:ITGR) are both mid-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their media sentiment, dividends, institutional ownership, earnings, valuation, community ranking, profitability, analyst recommendations and risk.

LivaNova presently has a consensus price target of $66.20, suggesting a potential upside of 6.86%. Integer has a consensus price target of $120.50, suggesting a potential upside of 5.55%. Given LivaNova's higher possible upside, equities research analysts clearly believe LivaNova is more favorable than Integer.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
LivaNova
0 Sell rating(s)
3 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.40
Integer
0 Sell rating(s)
2 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.67

In the previous week, LivaNova had 1 more articles in the media than Integer. MarketBeat recorded 8 mentions for LivaNova and 7 mentions for Integer. Integer's average media sentiment score of 0.81 beat LivaNova's score of 0.68 indicating that Integer is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
LivaNova
3 Very Positive mention(s)
1 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Integer
4 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

LivaNova received 5 more outperform votes than Integer when rated by MarketBeat users. Likewise, 68.78% of users gave LivaNova an outperform vote while only 63.39% of users gave Integer an outperform vote.

CompanyUnderperformOutperform
LivaNovaOutperform Votes
379
68.78%
Underperform Votes
172
31.22%
IntegerOutperform Votes
374
63.39%
Underperform Votes
216
36.61%

97.6% of LivaNova shares are held by institutional investors. Comparatively, 99.3% of Integer shares are held by institutional investors. 0.2% of LivaNova shares are held by company insiders. Comparatively, 2.0% of Integer shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Integer has a net margin of 6.01% compared to LivaNova's net margin of -2.68%. LivaNova's return on equity of 13.59% beat Integer's return on equity.

Company Net Margins Return on Equity Return on Assets
LivaNova-2.68% 13.59% 7.06%
Integer 6.01%11.25%5.69%

Integer has higher revenue and earnings than LivaNova. LivaNova is trading at a lower price-to-earnings ratio than Integer, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
LivaNova$1.19B2.83$17.55M-$0.60-103.25
Integer$1.63B2.34$90.65M$2.8939.50

LivaNova has a beta of 0.92, indicating that its stock price is 8% less volatile than the S&P 500. Comparatively, Integer has a beta of 1.12, indicating that its stock price is 12% more volatile than the S&P 500.

Summary

Integer beats LivaNova on 11 of the 18 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding LIVN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

LIVN vs. The Competition

MetricLivaNovaElectromedical equipment IndustryMedical SectorNASDAQ Exchange
Market Cap$3.35B$3.26B$5.16B$7.78B
Dividend YieldN/A1.68%2.84%3.96%
P/E Ratio-103.2510.03188.8319.04
Price / Sales2.8362.192,307.2685.27
Price / Cash14.9066.1233.5428.62
Price / Book2.613.975.314.62
Net Income$17.55M$87.99M$105.28M$217.57M
7 Day Performance-3.43%0.97%-0.26%0.58%
1 Month Performance12.15%-7.74%-2.28%-0.70%
1 Year Performance31.92%3.44%3.22%9.12%

LivaNova Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ITGR
Integer
1.7275 of 5 stars
$109.92
+0.1%
$120.50
+9.6%
+44.2%$3.68B$1.60B38.0310,500Insider Selling
TMDX
TransMedics Group
1.7366 of 5 stars
$124.44
+5.8%
$119.00
-4.4%
+70.6%$4.07B$241.62M-366.00584Insider Selling
CNMD
CONMED
4.9778 of 5 stars
$70.20
+2.7%
$107.86
+53.6%
-42.2%$2.16B$1.24B26.904,000Insider Buying
HAE
Haemonetics
4.2707 of 5 stars
$93.39
+1.4%
$104.67
+12.1%
+13.7%$4.68B$1.27B37.963,034Insider Selling
News Coverage
Gap Down
SLNO
Soleno Therapeutics
3.638 of 5 stars
$49.23
+3.6%
$55.60
+12.9%
+1,002.8%$1.64BN/A-16.5833Upcoming Earnings
News Coverage
Positive News
INMD
InMode
3.6156 of 5 stars
$17.36
+0.7%
$32.80
+88.9%
-47.1%$1.46B$492.05M7.55581
BLFS
BioLife Solutions
2.2785 of 5 stars
$18.16
+3.9%
$23.40
+28.9%
-4.2%$822.65M$143.27M-11.95409News Coverage
AXGN
AxoGen
2.4642 of 5 stars
$5.88
-10.4%
$10.67
+81.4%
-35.8%$257.02M$159.01M-11.31426
OM
Outset Medical
0.7602 of 5 stars
$3.00
+5.3%
$5.42
+80.6%
-83.9%$155.10M$130.38M-0.86480News Coverage
Gap Down
MASI
Masimo
4.6414 of 5 stars
$136.25
+1.7%
$137.43
+0.9%
-32.6%$7.09B$2.05B90.235,200Earnings Report
Analyst Forecast
News Coverage

Related Companies and Tools

This page (NASDAQ:LIVN) was last updated on 5/10/2024 by MarketBeat.com Staff

From Our Partners